Press Releases

DMC Press Release Square Optimized

DMC Secures $18M to Expand Health Ingredients Business

MORRISVILLE, NC — October 26, 2026 — DMC Biotechnologies (DMC), a U.S.-based health ingredient company developing high-purity, science-backed bioactives through precision fermentation, today announced that it has secured $18 M in financing. The financing was co-led by Inceptional Partners and Sofinnova Partners with strong participation from First Bight Ventures, and existing investors Cibus Capital and Capricorn Partners.

Dr. Jim Flatt Announced as New CEO of DMC Biotechnologies

MORRISVILLE, NC – January 14, 2025 – DMC Biotechnologies, a leader in synthetic biology and precision fermentation, is pleased to announce the appointment of Dr. James (Jim) Flatt as Chief Executive Officer, effective immediately. Dr. Flatt brings more than 30 years...

read more